ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesR87

R87

Abnormal findings in specimens from female genital organs

BILLABLE STATUSNo
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 R87 is a used to indicate a diagnosis of abnormal findings in specimens from female genital organs.

Key Diagnostic Point:

The ICD-10 Level 1 Category code R87 encompasses abnormal findings in specimens obtained from female genital organs. This category is crucial for identifying and coding various pathological conditions that may arise from cytological or histological examinations of specimens such as Pap smears, biopsies, and other diagnostic tests. Conditions covered under this category may include atypical squamous cells, dysplasia, and other abnormalities that warrant further investigation or intervention. Proper coding in this category is essential for accurate diagnosis, treatment planning, and monitoring of female reproductive health issues.

  • Clinically, the findings coded under R87 can indicate a range of conditions from benign lesions to precancerous changes and malignancies. The significance of these findings often necessitates follow-up procedures, additional testing, or referrals to specialists. Usage guidelines for R87 codes emphasize the importance of precise documentation to ensure that the findings are accurately represented and that the appropriate level of care is provided. This category plays a vital role in women's health management and preventive care strategies.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Variety of conditions covered
  • Need for precise documentation
  • Potential for follow-up procedures

Audit Risk Factors

  • Inadequate documentation
  • Misinterpretation of findings
  • Failure to follow up on abnormal results

Specialty Focus

Medical Specialties

Obstetrics and Gynecology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Pathology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Related Codes

Child Codes

37 codes
R87.0
Abnormal level of enzymes in specimens from female genital organs
R87.1
Abnormal level of hormones in specimens from female genital organs
R87.2
Abnormal level of other drugs, medicaments and biological substances in specimens from female genital organs
R87.3
Abnormal level of substances chiefly nonmedicinal as to source in specimens from female genital organs
R87.4
Abnormal immunological findings in specimens from female genital organs
R87.5
Abnormal microbiological findings in specimens from female genital organs
R87.6
Abnormal cytological findings in specimens from female genital organs
R87.61
Abnormal cytological findings in specimens from cervix uteri
R87.610
Atypical squamous cells of undetermined significance on cytologic smear of cervix (ASC-US)
R87.611
Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of cervix (ASC-H)
R87.612
Low grade squamous intraepithelial lesion on cytologic smear of cervix (LGSIL)
R87.613
High grade squamous intraepithelial lesion on cytologic smear of cervix (HGSIL)
R87.614
Cytologic evidence of malignancy on smear of cervix
R87.615
Unsatisfactory cytologic smear of cervix
R87.616
Satisfactory cervical smear but lacking transformation zone
R87.618
Other abnormal cytological findings on specimens from cervix uteri
R87.619
Unspecified abnormal cytological findings in specimens from cervix uteri
R87.62
Abnormal cytological findings in specimens from vagina
R87.620
Atypical squamous cells of undetermined significance on cytologic smear of vagina (ASC-US)
R87.621
Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of vagina (ASC-H)
R87.622
Low grade squamous intraepithelial lesion on cytologic smear of vagina (LGSIL)
R87.623
High grade squamous intraepithelial lesion on cytologic smear of vagina (HGSIL)
R87.624
Cytologic evidence of malignancy on smear of vagina
R87.625
Unsatisfactory cytologic smear of vagina
R87.628
Other abnormal cytological findings on specimens from vagina
R87.629
Unspecified abnormal cytological findings in specimens from vagina
R87.69
Abnormal cytological findings in specimens from other female genital organs
R87.7
Abnormal histological findings in specimens from female genital organs
R87.8
Other abnormal findings in specimens from female genital organs
R87.81
High risk human papillomavirus (HPV) DNA test positive from female genital organs
R87.810
Cervical high risk human papillomavirus (HPV) DNA test positive
R87.811
Vaginal high risk human papillomavirus (HPV) DNA test positive
R87.82
Low risk human papillomavirus (HPV) DNA test positive from female genital organs
R87.820
Cervical low risk human papillomavirus (HPV) DNA test positive
R87.821
Vaginal low risk human papillomavirus (HPV) DNA test positive
R87.89
Other abnormal findings in specimens from female genital organs
R87.9
Unspecified abnormal finding in specimens from female genital organs

Related CPT Codes

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The clinical impact of the R87 code category is significant, as it directly relates to women's health and the early detection of potential malignancies. Accurate coding can lead to timely interventions, improved patient outcomes, and enhanced quality of care. Administratively, the proper use of R87 codes can influence healthcare trends by highlighting the prevalence of abnormal findings and guiding resource allocation for preventive care initiatives.
Population health implications are also noteworthy, as the data collected through the use of R87 codes can inform public health strategies aimed at reducing the incidence of cervical and other reproductive cancers. By tracking abnormal findings, healthcare providers can identify at-risk populations and implement targeted screening and education programs, ultimately contributing to better health outcomes for women.

ICD-9 vs ICD-10

The clinical impact of the R87 code category is significant, as it directly relates to women's health and the early detection of potential malignancies. Accurate coding can lead to timely interventions, improved patient outcomes, and enhanced quality of care. Administratively, the proper use of R87 codes can influence healthcare trends by highlighting the prevalence of abnormal findings and guiding resource allocation for preventive care initiatives. Population health implications are also noteworthy, as the data collected through the use of R87 codes can inform public health strategies aimed at reducing the incidence of cervical and other reproductive cancers. By tracking abnormal findings, healthcare providers can identify at-risk populations and implement targeted screening and education programs, ultimately contributing to better health outcomes for women.

Reimbursement & Billing Impact

Reimbursement considerations include the complexity of the findings and the necessity for follow-up care. Providers should ensure that all documentation supports the coding used, as this will affect reimbursement rates and claims processing. It is also important to be aware of payer-specific guidelines that may influence billing practices.

Resources

Clinical References

  • •
    Official ICD-10 Guidelines for R87

Coding & Billing References

  • •
    Official ICD-10 Guidelines for R87

Frequently Asked Questions

What conditions are included in R87?

R87 includes abnormal findings such as atypical squamous cells, dysplasia, and other cytological or histological abnormalities detected in specimens from female genital organs.

When should I use R87 codes?

R87 codes should be used when reporting abnormal findings from diagnostic tests involving female genital specimens, particularly when further investigation or treatment is indicated.

What documentation is required for R87?

Documentation must include the type of specimen collected, the findings from the examination, and any recommendations for follow-up or additional testing.